Ordering and Reimbursement – ExEm Foam

FOR US AUDIENCES ONLY

Ordering and Reimbursementlwolfe632024-12-16T18:52:27+00:00

COMMITED TO PATIENT ACCESS

Ordering and Reimbursement

How to order ExEm^® Foam

Purchase through SendRx

Create your SendRx Account to begin ordering ExEm® Foam:
- Fill out the following brief informational form: AccountSetup – ExEm Foam
- Once your have submitted the form, an ExEm Foam will contact you with your login credentials and instructions on how to place an order.
- Visit our Frequently Asked Questions page or contact ExEm Foam for support on placing your orders: www.exemfoam.com/contact

Sending a prescription is quick and easy:

Your patient’s prescription for ExEm® Foam can be fulfilled through SendRx. You may send your prescription through your EMR system or through the SendRx portal.

Clinical Training and Product Samples

We are here to support your team and ensure you have the necessary training and educational resources to get started with ExEm® Foam. Learn how to sign up for our Clinical Adoption Program and receive product samples: www.exemfoam.com/clinical-adoption-program.

ExEm Foam provides comprehensive training and education on the safe and effective use of our products.

Guide to Coding & Reimbursement for Clinics

Let us guide you through the reimbursement process.

Contact the ExEm® Foam Reimbursement Advisor Team for guidance and assistance with industry compliant reimbursement procedures.

For support, call 1.888.963.EXEM (3936) or send an email to reimbursement@exemfoam.com.

No Insurance or Denied Claims

If your patient doesn’t have insurance, or her insurance doesn’t cover ExEm® Foam, she may pay for ExEm® Foam out-of-pocket through SendRx.

Reimbursement Avisor Team Support for Clinics and Physicians

To contact our Reimbursement Advisor Team, call 1.888.963.EXEM (3936) or send an email to reimbursement@exemfoam.com.

ExEm® Foam is an innovative, FDA-approved product that offers a less invasive and effective alternative to other tubal patency assessment procedures, like laparoscopy or X-Ray HSG.

ExEm^® Foam Inc. is an affiliate of IQ MEDICAL VENTURES, B.V. ExEm^® is a registered trademark of GISKIT PHARMA B.V.

Important Safety Information: ExEm^® Foam should not be used on patients who are pregnant, have known or suspected lower genital tract inflammation or infection, have had a gynecologic procedure within the last 30 days, have vaginal bleeding, or have known or suspected reproductive tract neoplasia. Common side effects include pelvic and abdominal pain, vasovagal reactions (and associated symptoms such as nausea and faintness), and post-procedure spotting. Click here for full prescribing information.

References:

‍1. Ludwin I., Ludwin, A. et al. Accuracy of hysterosalpingo-foam sonography in comparison to hysterosalpingo-contrast sonography with air/saline and to laparoscopy with dye. Human Reproduction 2017, 32(4):758–69
‍
‍2. Riganelli L., Casorelli A. et al. Ultrasonography reappraisal of tubal patency in assisted reproduction technology patients: comparison between 2D and3D-sonohysterosalpingography. A pilot study. Minerva Ginecologica 2018, 70(2):123-28
‍
3. Dreyer, K., Out, R. et al. Hysterosalpingo-foam sonography, a less painful procedure for tubal patency testing during fertility workup compared with (serial) hysterosalpingography: A randomized controlled trial. Fertility and Sterility 2014, 102(3):821-25

ExEm_US_02_v27

ExEm^® Foam Inc. is an affiliate of IQ MEDICAL VENTURES, B.V. ExEm^® is a registered trademark of GISKIT PHARMA B.V.